chartexchange

EDIT
Editas Medicine, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
1.78USD-2.466%(-0.05)1,991,191
Pre-marketNov 18, 2026 9:16:30 AM EST
1.89USD+3.562%(+0.07)
After-hoursNov 18, 2026 4:37:30 PM EST
1.79USD+0.562%(+0.01)
Loading…
Loading…
274.72M
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$1.83
Beta
2.38
52-Week High
$3.94 2026-05-27
52-Week Low
$1.66 2026-02-05
SMA 50
$2.56
SMA 200
$2.70
Avg. Vol 10D
2.40M
Avg. Vol 30D
2.38M
Avg. Vol 90D
2.43M
Relative Vol
0.84
154.34M
139.21M
38,720,295
0.2900%
446
Mar 8, 2027 (109d)
EDIT Profile

unlocking the promise of genome editing to deliver life-changing medicines. editas medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

EDIT Performance
PeriodPriceDateChangeBeta
1W2.142026-11-12-16.82%7.894
1M2.422026-10-19-26.45%2.649
3M3.252026-08-19-45.23%3.003
6M2.462026-05-19-27.64%2.296
1Y2.522025-11-19-29.36%2.378
2Y2.482024-11-19-28.23%—
5Y35.352021-11-19-94.97%2.095
EDIT Stock Summary

Editas Medicine, Inc. Common Stock (NASDAQ:EDIT) stock price today is $1.78, and today's volume is 1,991,191. EDIT is down 2.466% today. The 30 day average volume is 2.38M. EDIT market cap is $274.72M with 154.34M shares outstanding.